Recent studies have also shown that microRNA miR-124 reduces the survival of MDA-MB-231 breast cancer cells in the in vivo bone microenvironment and repressed cancer cell-induced osteolytic disease after intratibial injection via downregulation of IL-11 [127]. The gene discussed is IL11; the disease is breast carcinoma.